From: The impact of ABCB1, CYP3A4/5 and ABCG2 gene polymorphisms on rivaroxaban trough concentrations and bleeding events in patients with non-valvular atrial fibrillation
Variables
Characteristics of patients (95)
Age (years)
65.8 ± 12.5
Female, n (%)
39 (41.0)
Body weight (kg)
67.8 ± 12.2
CrCl (mL/min)
77.3 ± 23.4
Dose, n (%)
10 mg qd
21 (22.1)
15 mg qd
71 (74.7)
20 mg qd
3 (3.2)